Compared to bare-metal stents (BMSs), drug-eluting stents (DESs) have been regarded as a
revolutionary change in coronary artery diseases (CADs). Releasing pharmaceutical agents …

The power prior has been widely used in many applications covering a large number of
disciplines. The power prior is intended to be an informative prior constructed from historical …

Importance Use of intravascular ultrasound (IVUS) promotes better clinical outcomes for
coronary intervention in complex coronary lesions. However, randomized data …

Background: Previous meta-analyses have investigated the relative safety and efficacy
profiles of different types of drug-eluting stents (DES) and bare-metal stents (BMS); however …

Some surveys have shown that the intended users are sometimes unaware of the existence
of guidelines, or simply do not translate them into practice. Thus, implementation …

Background—Drug-eluting stents (DES) have been in clinical use for nearly a decade;
however, the relative short-and long-term efficacy and safety of DES compared with bare …

Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

Background Whether the two drug-eluting stents approved by the US Food and Drug
Administration—a sirolimus-eluting stent and a paclitaxel-eluting stent—are associated with …

Background The safety of drug-eluting stents has been called into question by recent reports
of increased stent thrombosis, myocardial infarction, and death. Such studies have been …

Background Definitions of stent thrombosis that have been used in clinical trials of drug-
eluting stents have been restrictive and have not been used in a uniform manner. Methods …